Rahul K. Reddy – Pharmacology – Excellence in Research

Published on by Top Pharmaceutical

Rahul K. Reddy - Pharmacology - Excellence in Research

Lautoka Hospital - Fiji

Introduction

Rahul K. Reddy is an accomplished researcher and medical professional specializing in urology, surgery, and trauma care. With a focus on advancing medical understanding and clinical outcomes in challenging cases, Dr. Reddy has contributed significantly to the fields of laparoscopic surgery, burn care, and acute surgical conditions. His work is characterized by its depth of clinical insight and dedication to improving patient outcomes in diverse healthcare settings, particularly in Fiji.

Laparoscopic Surgery in Urology

Dr. Reddy's pioneering work in the laparoscopic excision of seminal vesicle cystadenoma underscores his expertise in minimally invasive surgical techniques. Published in Urology Case Reports (2019), this study has provided valuable insights into rare urological conditions, offering innovative approaches to their management.

Burn Injury Characteristics and Outcomes

In collaboration with a multidisciplinary team, Dr. Reddy conducted an in-depth analysis of burn injury patterns and treatment outcomes at Lautoka Hospital. His findings, featured in Burns Open (2024), have contributed to the optimization of burn care protocols in resource-limited settings, enhancing recovery rates and patient care quality.

Acute Appendicitis Management

Through an observational retrospective study on acute appendicitis at Lautoka Aspen Hospital, Dr. Reddy explored the clinical characteristics and outcomes over a one-year period (2022–2023). Published in World Journal of Surgical Research (2024), this research offers evidence-based recommendations for improving appendicitis management in Pacific Island healthcare systems.

Rare Tumors and Pathologies

Dr. Reddy has also delved into the study of rare pathologies, such as primary epithelioid hemangioendothelioma of the kidney pelvis. His case report, published in the American Journal of Surgery and Clinical Case Reports (2020), adds to the limited literature on this rare tumor type, emphasizing the importance of early diagnosis and tailored surgical interventions.

Trauma and Emergency Medicine

With a holistic approach to trauma care, Dr. Reddy's research addresses the critical needs of patients in emergency settings. His work highlights the significance of multidisciplinary collaboration and protocol-driven management in achieving favorable outcomes for complex trauma cases.

Conclusion

Rahul K. Reddy’s extensive research portfolio reflects his unwavering commitment to advancing medical science and improving patient care. By addressing diverse challenges in urology, surgery, and trauma care, Dr. Reddy continues to contribute to the development of innovative treatments and clinical best practices, with a lasting impact on global and regional healthcare.

NOTABLE PUBLICATION

Laparoscopic excision of seminal vesicle cystadenoma 2019 (4)

Burns injury characteristics and outcomes at lautoka hospital, fiji 2024

Characteristics and Outcomes of Acute Appendicitis in Lautoka Aspen Hospital, Fiji: An Observational Retrospective Study (09/22–09/23) 2024

Primary Epithelioid Hemangioendothelioma of the Kidney Pelvis 2020

Khalid M Alkharfy| Herbal Medicine and Nutraceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Dr. Khalid M Alkharfy| Herbal Medicine and Nutraceuticals | Best Researcher Award

King Saud University, Saudi Arabia

Author Profile

Early Academic Pursuits 🎓

Prof. Dr. Khalid M. Alkharfy began his academic journey with an unwavering commitment to pharmaceutical sciences. Graduating with class honors from King Saud University in 1992 with a Bachelor of Pharmaceutical Sciences (B.Sc. Pharm), he established a solid foundation for his future contributions to the field. His academic excellence continued as he pursued a Doctor of Pharmacy (Pharm.D) at the University of Tennessee, USA, graduating in 1997 with class honors. During this period, Dr. Alkharfy honed his skills as a pharmacy intern at leading healthcare institutions in Memphis, Tennessee, including Veterans Affairs Medical Center, Regional Medical Center, and Baptist Memorial Hospital. This formative training emphasized his proficiency in adjusting and monitoring drug therapies, providing patient counseling, and collaborating with multidisciplinary medical teams.

Furthering his expertise, Dr. Alkharfy earned a Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences from the University of Pittsburgh in 2002. This significant achievement, recognized with distinction in clinical research, underscored his ability to conduct groundbreaking studies and set the stage for his impactful career in clinical and translational research.

Professional Endeavors and Leadership 🏢

Dr. Alkharfy’s professional journey is characterized by a series of prominent leadership roles, showcasing his scientific acumen and administrative capabilities. Starting as a Clinical Instructor at King Khalid University Hospital (1992-1994), he contributed to training pharmacy students while working with the nephrology medical team. His academic and research career blossomed further during his tenure as a Research Associate (1997-2002) at the University of Pittsburgh Medical Center, where he played a pivotal role in designing and conducting clinical trials, analyzing data, and disseminating findings through conferences and publications.

Returning to Saudi Arabia, Dr. Alkharfy joined King Saud University in 2002 as a Professor of Clinical and Translational Research in the Department of Clinical Pharmacy. In this capacity, he has led numerous initiatives, including the Translational and Drug Discovery Unit and the Biomarkers Research Program, focusing on metabolic disorders and diabetes. His leadership extended beyond academia as he served as Dean of the College of Pharmacy at Prince Sattam University (2013-2016) and as the Founding Dean of Almaarefa University’s College of Pharmacy (2011-2013).Additionally, Dr. Alkharfy took on national responsibilities as a Consultant for the Saudi Food and Drug Authority (SFDA), advising on regulatory frameworks and ensuring pharmaceutical standards. His global contributions include Visiting Scholar positions at renowned institutions such as Mayo Clinic (USA), the University of Hong Kong, and Charles University (Czech Republic).

Contributions and Research Focus 🔬

Dr. Alkharfy has made profound contributions to clinical and translational research, with a focus on metabolic disorders, diabetes, and drug discovery. As a leader in the Biomarkers Research Program, he has designed innovative studies to identify novel therapeutic targets and biomarkers for chronic diseases. His expertise has also extended to creating an ecosystem for R&D projects as Director of Riyadh Techno Valley, where he fostered collaborations between academia, industry, and government to advance Saudi Arabia’s science and technology infrastructure.Dr. Alkharfy has authored and co-authored over 260 scientific papers, abstracts, and publications, many of which have appeared in high-impact, peer-reviewed journals. His work demonstrates a commitment to advancing global health through robust research methodologies and interdisciplinary collaboration.

Accolades and Recognition 🏆

Over the years, Dr. Alkharfy’s accomplishments have garnered international recognition. As a Fulbright Scholar at Mayo Clinic (2019), he contributed to advanced clinical research in diabetes and pharmacotherapy. His expertise earned him invitations to prestigious visiting scholar positions at leading universities worldwide, including the University of Campinas (Brazil), International Islamic University Malaysia, and the University of Auckland (New Zealand).Dr. Alkharfy’s innovation is further evidenced by his four registered patents across Saudi Arabia, the USA, and Europe, reflecting his commitment to translating research into tangible solutions. His leadership as Dean and consultant roles have been instrumental in shaping pharmacy education and regulatory practices in Saudi Arabia.

Impact and Influence 🌍

Dr. Alkharfy’s work has had a lasting impact on both academia and public health policy. As a leader in clinical and translational research, his studies on diabetes and metabolic disorders have influenced treatment paradigms, while his patents have contributed to drug discovery and development. His mentorship of young scientists and pharmacy students has inspired a new generation of researchers and clinicians in Saudi Arabia and beyond.

Through his roles in national regulatory bodies and academic institutions, Dr. Alkharfy has played a critical part in strengthening the research infrastructure in Saudi Arabia, promoting innovation, and aligning the country’s scientific endeavors with international standards.

Legacy and Future Contributions 🌟

As Dr. Khalid M. Alkharfy continues his illustrious career, his legacy is firmly rooted in his dedication to research excellence, leadership, and education. His work has set a benchmark for integrating clinical and translational research with public health initiatives, fostering international collaborations, and nurturing talent in pharmaceutical sciences.

📖Notable Publications

Effect of physical activity and sun exposure on vitamin D status of Saudi children and adolescents
  • Authors : Abdulaziz Al-Othman, Sara Al-Musharaf, Nasser M Al-Daghri, Soundararajan Krishnaswamy, Deqa S Yusuf, Khalid M Alkharfy, Yousef Al-Saleh, Omar S Al-Attas, Majed S Alokail, Osama Moharram, Shaun Sabico, George P Chrousos
  • Journal: BMC pediatrics
  • Year: 2012
Association of VDR-gene variants with factors related to the metabolic syndrome, type 2 diabetes and vitamin D deficiency
  • Authors : Nasser M Al-Daghri, Omar S Al-Attas, Khalid M Alkharfy, Nasiruddin Khan, Abdul Khader Mohammed, Benjamin Vinodson, Mohammed Ghouse Ahmed Ansari, Amal Alenad, Majed S Alokail
  • Journal: Gene
  • Year: 2014
Momordica charantia polysaccharides ameliorate oxidative stress, inflammation, and apoptosis in ethanol-induced gastritis in mucosa through NF-kB signaling pathway inhibition
  • Authors : Mohammad Raish, Ajaz Ahmad, Mushtaq Ahmad Ansari, Khalid M Alkharfy, Fahad I Aljenoobi, Basit L Jan, Abdullah M Al-Mohizea, Altaf Khan, Naushad Ali
  • Journal: Biological Macromolecules
  • Year: 2018
Irisin as a predictor of glucose metabolism in children: sexually dimorphic effects
  • Authors : Nasser M Al‐Daghri, Khalid M Alkharfy, Shakilur Rahman, Osama E Amer, Benjamin Vinodson, Shaun Sabico, Milan K Piya, Alison L Harte, Philip G McTernan, Majed S Alokail, George P Chrousos
  • Journal: European Journal of Clinical Investigation
  • Year: 2014
Application of Box–Behnken design for ultrasonic-assisted extraction of polysaccharides from Paeonia emodi
  • Authors : Ajaz Ahmad, Khalid M Alkharfy, Tanveer A Wani, Mohammad Raish Ansari; Muzaffar Iqbal; Ali N; Alkharfy KM et al.
  • Journal:biological macromolecules
  • Year: 2015

Ajaz Ahmad| Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Ajaz Ahmad | Drug Delivery Systems| Best Researcher Award

 King Saud University, Saudi Arabia

Author Profile

🎓Early Academic Pursuits 

Professor Ajaz Ahmad began his distinguished academic journey at the prestigious Hamdard University in New Delhi, India. He earned a Bachelor of Pharmacy (B.Pharm) in 2005, where he demonstrated an early inclination toward pharmaceutical sciences. Continuing his education at the same institution, he completed a Master of Pharmacy (M.Pharm) in 2007, refining his focus on drug delivery and molecular pharmacology. Driven by a passion for research, he pursued a Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences, which he completed in 2011. His doctoral research laid the foundation for his expertise in drug discovery, pharmacokinetics, and the molecular mechanisms underpinning drug actions.

💼Professional Endeavors 

King Saud University, Saudi Arabia
Prof. Ahmad joined the College of Pharmacy at King Saud University in 2011 as an Assistant Professor in Clinical Pharmacy. Over the next decade, his contributions to research and teaching led to successive promotions—first as an Associate Professor in 2017 and then to his current role as Professor in Clinical Pharmacy in January 2024. At King Saud University, Prof. Ahmad’s role encompasses teaching advanced courses, mentoring postgraduate students, and conducting cutting-edge research in pharmacology and drug development.International Collaborations
Since 2015, Prof. Ahmad has served as a research collaborator with the Mayo Clinic, USA, a testament to his global reputation in pharmaceutical sciences. In 2013, he was appointed an Honorary Research Associate at the University of Hong Kong, further broadening his academic and professional network.Patents and Industry EngagementProf. Ahmad holds a U.S. patent (US20170231925A1) for treating neurovascular complications of diabetes mellitus. This innovation highlights his commitment to bridging the gap between research and practical healthcare applications.

🔬Contributions and Research Focus 

Prof. Ahmad’s research covers a broad spectrum of topics in pharmaceutical sciences, with particular focus areas including:Preclinical Drug Development: He has explored novel therapeutic agents, focusing on their efficacy, safety, and molecular mechanisms.Pharmacokinetics and Drug Metabolism: His work delves into the ADME (absorption, distribution, metabolism, and excretion) properties of drugs, optimizing formulations and dosing regimens.Bioanalytical Method Development: Prof. Ahmad designs and validates analytical methods for drug quantification, ensuring reproducibility and precision.Animal Models for Disease Research: He conducts in vivo studies simulating human diseases like cancer, diabetes, and cardiovascular disorders, with a focus on ethical handling and translational applications.Sepsis Research: Investigating biomarkers for early diagnosis and developing therapeutic strategies to combat sepsis.Vascular Pharmacology: Using myography techniques, he explores interventions for vascular diseases and evaluates novel therapeutic targets.

📖Notable Publications

Molecular insights into anti-Protozoal action of natural compounds against
  • Authors : Raish M; Ahmad A; MOHD SHAHNAWAZ KHAN; Kalam MA
  • Journal: biomolecular structure & dynamics
  • Year: 2023
A BOX-BEHNKEN DESIGN FOR OPTIMIZATION OF ULTRASOUND-ASSISTED EXTRACTION OF SINAPIC ACID FROM FRAGARIA ANANASSA
  • Authors : Mudassar Shahid; Ahmad A; Raish M; Bin Jardan YA; Alkharfy KM; Ahad A; Abul Kalam M; Ahmad Ansari M; Iqbal M; Ali N et al.
  • Journal: Pharmaceutical Society
  • Year: 2023
Sinapic acid alleviates 5-fluorouracil-induced nephrotoxicity in rats via Nrf2/HO-1 signalling.
  • Authors : Ahmad Ansari M; Shahid M; Ahmad SF; Ahmad A; Alanazi A; Malik A; Bin Jardan YA; Attia SM; Bakheet SA; Raish M
  • Journal: Pharmaceutical Sciences
  • Year: 2023
A large particle size is required by a nano/micron sized-fluticasone propionate inhalable suspension for asthma treatment
  • Authors : Zhang, M., Si, S.J., Dai, W.J., … Jin, F., Jiang, L.Q.
  • Journal: Pharmaceutical Society
  • Year: 2023
Effects of Apigenin on Pharmacokinetics of Dasatinib and Probable Interaction Mechanism.
  • Authors : Mohammad raish; Ahmad A; Mudassar Shahid; Yousef A Bin Jardan; Abdul Ahad; Dr Mohd Abul Kalam; Mushtaq Ahmad Ansari; Muzaffar Iqbal; Ali N; Alkharfy KM et al.
  • Journal:Molecules
  • Year: 2023

Liqun Jiang | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Assist. Prof. Dr. Liqun Jiang | Drug Delivery Systems | Best Researcher Award

Xuzhou Medical University, China

Author Profile

🎓Early Academic Pursuits 

Liqun Jiang began his academic journey with a deep interest in pharmaceutical sciences and biotechnology. His foundational studies were driven by a passion for discovering innovative solutions to pressing medical challenges. During his early years, Jiang demonstrated exceptional aptitude in the fields of drug development and delivery systems, excelling in both theoretical and applied sciences. These formative experiences laid the groundwork for his future endeavors in advanced pharmaceutical research. Jiang’s dedication to academic excellence led him to pursue specialized training and advanced education, equipping him with the knowledge and skills essential for groundbreaking contributions to medical science.

🌟Professional Endeavors 

Currently serving as an Associate Professor at Xuzhou Medical University, Liqun Jiang has established himself as a key figure in pharmaceutical engineering. His role extends beyond teaching, as he actively participates in high-impact research initiatives. A youth member of the Pharmaceutical Engineering Committee of the Chinese Pharmaceutical Society, Jiang is deeply involved in projects focused on novel drug delivery systems, particularly for respiratory diseases.

He has been instrumental in nearly 10 prestigious research projects, including the national 863 Program and major drug innovation programs. Jiang has successfully overseen the development of approximately 10 products, ranging from pharmaceuticals and disinfection solutions to specialized medical foods. His collaborative efforts with pharmaceutical companies have led to the development of a drug liposome inhalation agent, which has now progressed to pilot production stages.

🔬Contributions and Research Focus 

Jiang Liqun’s research is primarily centered on novel drug delivery systems for respiratory diseases, with a particular emphasis on pulmonary edema. His contributions to the field are both diverse and impactful, including: Developing pressure-sensitive multivesicular liposomes for delivering amlodipine besylate, Innovating therapies with exogenous eNOS genes to combat high-altitude pulmonary edema, Utilizing mesenchymal stem cell exosomes for advanced inhalation therapies, Designing high-efficiency powder mist inhalants for high-altitude conditions.

🏆Accolades and Recognition 

Liqun Jiang’s academic and professional achievements have garnered widespread recognition. His research contributions are evidenced by: Nearly 30 peer-reviewed publications in reputed journals, 10 authorized patents, with 8 more under processing, An impressive citation index of 312, reflecting the high impact of his work, Close collaborations with pharmaceutical companies, leading to tangible advancements in drug development and commercialization, Jiang’s dedication to his field is further highlighted by his active participation in the Chinese Pharmaceutical Society, where he contributes as a youth member in shaping the future of pharmaceutical engineering.

🌏Impact and Influence 

Jiang Liqun’s work has had a profound impact on both academia and industry. His innovative strategies for addressing respiratory diseases have paved the way for safer, more effective therapeutic interventions. By integrating cutting-edge drug delivery systems into clinical practice, Jiang has set a benchmark in the treatment of pulmonary conditions. His ability to bridge the gap between research and application has made him a valuable collaborator for pharmaceutical companies seeking to bring advanced therapies to market.

🌟Legacy and Future Contributions 

Jiang Liqun’s legacy lies in his relentless pursuit of innovation and excellence in pharmaceutical research. His groundbreaking work in drug delivery systems has already influenced the development of treatments for high-altitude pulmonary edema and other respiratory conditions. Looking ahead, Jiang aims to expand his research into broader areas of pulmonary medicine, focusing on the use of biotechnology and nanotechnology in drug development. He envisions a future where precision medicine and targeted therapies play a pivotal role in treating respiratory diseases, improving outcomes for patients worldwide. Jiang is committed to mentoring the next generation of researchers and fostering collaborations that advance the frontiers of pharmaceutical science.

🌟Final Thoughts 

With a career marked by innovation, dedication, and impactful contributions, Liqun Jiang exemplifies the qualities of a trailblazing researcher. His work continues to shape the future of respiratory medicine, leaving an indelible mark on both academia and industry. Through his ongoing efforts, Jiang inspires a new wave of scientific inquiry and collaboration, ensuring his legacy will resonate for years to come.

📖Notable Publications

Pressure-sensitive multivesicular liposomes as a smart drug-delivery system for high-altitude pulmonary edema
  • Authors : Li, H., Liu, S., Dai, W., … Jin, F., Jiang, L.
  • Journal: Controlled Release
  • Year: 2024
Inhalation of panaxadiol alleviates lung inflammation via inhibiting TNFA/TNFAR and IL7/IL7R signaling between macrophages and epithelial cells
  • Authors : Wang, Y., Wei, H., Song, Z., … Shu, Q., Xie, Y.
  • Journal: Ginseng Research
  • Year: 2024
Dry Powder Formulations for Inhalation Require a Smaller Aerodynamic Diameter for Usage at High Altitude
A large particle size is required by a nano/micron sized-fluticasone propionate inhalable suspension for asthma treatment
A simple liposome-based bionic bacterium for tumor treatment by re-education of tumor-associated microphages in combination with chemotherapy

Ms. Frezer Kedir|Personalized Medicine|Women Researcher Award

Published on by Top Pharmaceutical

Ms. Frezer Kedir-Personalized Medicine-Women Researcher Award

Ms. Frezer Kedir at Institute of Health, Jimma University, Ethiopia

Author Profile

Early Academic Pursuits 🎓

Frezer Kedir Menu’s academic journey began with a strong foundation in primary education at Ingibi Elementary School and Ras Tesema Nado Elementary School. She demonstrated early promise, which propelled her to pursue her secondary education at Bedele Secondary School, completing it with distinction.

Frezer’s higher education commenced at KE-MED Medical College, where she acquired foundational medical knowledge between 1998 and 2001. Building on her passion for healthcare and academic excellence, she enrolled at Jimma University, earning a Bachelor of Science (BSc) degree in 2016. Driven by her unwavering commitment to advancing her knowledge and skills, she pursued a Master’s degree in Adult Health Nursing at the same university, completing it in 2024 with a commendable GPA of 3.64.

Professional Endeavors 💼

Frezer has accumulated over 12 years of hands-on experience in clinical healthcare, showcasing her dedication to patient care and medical excellence. She is currently serving as a Program Facilitator, a role that involves designing, implementing, and overseeing healthcare programs to ensure maximum impact. Her work reflects a deep understanding of clinical protocols and the ability to address complex health challenges in diverse settings.

Her career is not only defined by her clinical acumen but also by her commitment to fostering positive patient outcomes and empowering healthcare teams. Frezer’s experience in facilitating programs underscores her strong leadership capabilities and ability to drive organizational objectives effectively.

Contributions and Research Focus 🧪

Frezer’s research contributions highlight her dedication to addressing critical healthcare issues in Ethiopia. Her work spans a range of topics that directly impact patient care and public health, including:

  1. Dietary Knowledge and Its Associated Factors Among Diabetic Patients (2016):
    A study aimed at understanding dietary knowledge among diabetic patients at Jimma Medical Center, emphasizing the importance of nutrition in managing diabetes.
  2. Unmet Supportive Care Needs Among Cancer Patients (2023):
    This research explored the gaps in supportive care for cancer patients, providing insights into improving palliative care and patient support systems.
  3. Patient Engagement in Healthcare Decision-Making (2023):
    A project examining how patients with chronic non-communicable diseases in Southern Ethiopia engage in healthcare decisions, highlighting the significance of shared decision-making.
  4. Patient Autonomy in Managing Brachial Asthma (2024):
    This study focused on promoting patient autonomy and self-management in asthma care, offering strategies for better healthcare delivery in Southern Ethiopia.

Accolades and Recognition 🏆

Frezer’s work has earned her several certifications and accolades, which attest to her professional commitment and continuous growth. Notable achievements include:

  • Leadership Training Certificate: Demonstrating her ability to lead and train healthcare teams effectively.
  • PMTCT Training: Equipping her with essential skills to prevent mother-to-child transmission of diseases.
  • CISCO Certification: Enhancing her technical competencies in basic computer skills.
  • Operational Smile Training: Recognizing her contribution to healthcare training programs.
  • Developmental Team Training Certificate: Reflecting her focus on team-building and operational efficiency.

Impact and Influence 🌍

Frezer’s contributions extend beyond research and clinical work. Her role as a program facilitator allows her to influence healthcare delivery systems, ensuring they are inclusive and patient-centered. Through her research, she has shed light on critical healthcare gaps, prompting improvements in dietary education, supportive care, patient autonomy, and engagement in decision-making processes.

Legacy and Future Contributions 🌟

Frezer’s dedication to healthcare is creating a legacy of improved patient outcomes and enhanced healthcare systems in Ethiopia. Her research continues to inspire evidence-based practices, and her leadership in program facilitation fosters a culture of excellence within her teams.

In the future, Frezer aims to expand her impact by contributing to national healthcare policies, mentoring young professionals, and advocating for research-driven solutions to pressing healthcare challenges. She envisions a healthcare system that is both accessible and equitable, ensuring that every patient receives the care they deserve.

Notable Publications

Engagement in healthcare decision-making and associated factors among patients with chronic non-communicable diseases in Southwest Ethiopia

  • Authors   : Abdulwehab, S., Belay, Y., Kedir, F., Yimam, E., Belay, A.
  • Year         :2024

Patient autonomy in self-managing their bronchial asthma exacerbation and its associated factors,

      • Authors   : Abdulwehab, S., Kedir, F.
      • Year         :2024

       

Dr. Metin Eser|Medical Genetics|Best Researcher Award

Published on by Top Pharmaceutical

Dr. Metin Eser-Medical Genetics-Best Researcher Award

Dr. Metin Eser at mraniye Education and Research Hospital, University of Health Sciences, Istanbul, Turke

Author Profile

Orcid

🎓Educational Background

  • Medical Genetics Specialist: Pamukkale University Faculty of Medicine (2009–2013)
  • Medical Degree: Ondokuz Mayıs University Faculty of Medicine (1987–1996)
  • High School: Malatya High School, Malatya (1983–1986)
  • Secondary & Primary Education: Yakınca Secondary and Primary Schools, Malatya (1976–1983)

🧠Professional Experience

  • Medical Genetics Specialist:
    • Istanbul Health Sciences University, Ümraniye Training and Research Hospital (2019–Present)
    • Aydın State Hospital (2016–2019)
    • Medeniyet University, Göztepe Training and Research Hospital (2013–2016)
  • Research Assistant:
    • Pamukkale University Faculty of Medicine, Department of Medical Genetics (2009–2013)
    • Ankara Numune Training and Research Hospital, Emergency Medicine (2007–2009)
    • Gaziantep University Faculty of Medicine, Pathology (2005–2007)
  • General Practitioner and Institutional Roles:
    • Multiple roles in healthcare centers and hospitals across Turkey, including TCDD Ankara Hospital and Şahnahan Health Center.

🏆Specialization Thesis

Title: Investigation of CHGA Gene Promoter Region Polymorphisms in Cases with Essential Hypertension
Advisor: Assoc. Prof. Dr. C. Nur Semerci (2012)

🌍Scientific Contributions

Dr. Eser has co-authored numerous peer-reviewed publications in internationally recognized journals such as American Journal of Human Genetics, Balkan Medical Journal, Clinical Dysmorphology, and European Journal of Endocrinology. His work spans topics such as genetic mutations, chromosomal abnormalities, and rare syndromes like Cantu and Rubinstein-Taybi.

🌟Conference Presentations

Dr. Eser has presented his findings at prestigious gatherings, including the European Human Genetics Conference (2017) in Copenhagen and several national medical genetics congresses in Turkey.

Notable Publication

Expanding the clinical and genetic landscape of (developmental) epileptic encephalopathy with spike-and-wave activation in sleep: results from studies of a Turkish cohort

  • Authors   : Tuerkyilmaz, Ayberk; Sager, Safiye Guenes; Tekin, Emine; Terali, Kerem; Duezkalir, Hanife; Eser, Metin; Akin, Yasemin
  • Journal    :Neurogenetics
  • Year         :2024

Homozygous Frameshift Mutation In Ceruloplasmin Gene That Causing Neurodegeneration, Dementia With Diabetes In A Turkish Man: A Case Report

      • Authors   : Canbek, Sezin; Eser, Metin; Yarar, Murat Hakki
      • Journal    : European Journal of Human Genetics
      • Year         :2024

Natural history of ENPP1 deficiency: Nationwide Turkish Cohort Study of autosomal-recessive hypophosphataemic rickets type 2

    • Authors   : Dursun, Fatma; Turan, Ihsan; Bitkin, Eda celebi; Bayramoglu, Elvan; Cayir, Atilla; Erdeve, Senay Savas; Cakir, Esra Deniz Papatya;
    • Journal    : Clinical Endocrinology
    • Year         :2024

 

Severe adrenal insufficiency in six neonates with normal newborn screening for CAH

    • Authors   :Ilknur Kurt; Metin Eser; Ahmet Kahveci; Ahmet Ucar; Derya Bulus; Bahar Ozcabi; Omer Guran; Selen Karagozlu; Aysenur Ersoy; Senol Demir et al.
    • Journal    : Clinical Endocrinology
    • Year         :2024

Clinical and genetic spectrum from a prototype of ciliopathy: Joubert syndrome

    • Authors   :  Uzunhan, Tugce Aksu; Erturk, Biray; Aydin, Kuersad; Ayaz, Akif; Altunoglu, Umut; Yarar, Murat Hakki; Gezdirici, Alper; Icagasioglu, Dilara Fuesun;
    • Journal    : Clinical Neurology and Neurosurgery
    • Year         :2023

Mr. Sun Hui|Formulation Science|Best Researcher Award

Published on by Top Pharmaceutical

Mr. Sun Hui-Formulation Science-Best Researcher Award

Mr. Sun Hui at ollege of Computer Science and Technology, Harbin Engineering University, China

Author Profile

scopus

Early Academic Pursuits 🎓

Sun Hui embarked on his academic journey at a young age, demonstrating a keen interest in technology and innovation. He pursued his undergraduate studies at the College of Computer Science and Technology, Harbin Engineering University, China, where he developed a solid foundation in computational sciences and engineering principles. His exceptional performance and enthusiasm for research earned him numerous accolades during his undergraduate years.

Continuing his academic pursuit, Sun Hui delved deeper into advanced topics such as electromagnetic scattering and artificial intelligence, laying the groundwork for his future contributions to science and technology. He completed his postgraduate studies with distinction, focusing on integrating computational methods with real-world applications, setting the stage for a thriving career in academia and research.

Professional Endeavors 🚀

Mr. Sun Hui currently holds dual roles as a researcher at the Institute of Systems Engineering, Academy of Military Science, and a doctoral supervisor at Harbin Engineering University. His professional journey has been marked by a steadfast commitment to advancing the fields of computer science and systems engineering.

At the Academy of Military Science, Sun Hui has been pivotal in developing innovative applications for electromagnetic scattering, which are essential for modern defense and communication systems. Meanwhile, as a mentor at Harbin Engineering University, he has guided numerous doctoral candidates, fostering a new generation of researchers equipped to tackle global technological challenges.

Contributions and Research Focus 🧠

Sun Hui has made significant strides in several cutting-edge areas of science and technology. His primary research interests include:

  • Electromagnetic Scattering: Contributing to the understanding and application of electromagnetic waves in complex environments, essential for radar and communication technologies.
  • Sensor Big Data: Developing advanced algorithms to process and analyze large volumes of sensor-generated data, enabling more efficient decision-making systems.
  • Artificial Intelligence (AI) Theory: Innovating methods to enhance machine learning and AI systems’ accuracy, reliability, and scalability.

In recent years, Sun Hui has concentrated on the “Intelligence+” framework and AI for Science research paradigm innovation. This visionary approach merges traditional scientific methodologies with advanced AI techniques, unlocking new possibilities in data analysis, simulation, and predictive modeling. His work is regarded as transformative, fostering interdisciplinary collaborations and pushing the boundaries of computational science.

Accolades and Recognition 🏆

Sun Hui’s contributions have earned him widespread recognition within academic and professional communities. His accolades include:

  • Prestigious research awards from national and international institutions.
  • Publication of high-impact research papers in leading journals in computer science and engineering.
  • Invitations to deliver keynote speeches at global conferences, sharing insights on the intersection of AI, big data, and science.

His efforts have also been acknowledged through funding grants that support innovative research projects, further solidifying his position as a leading figure in his field.

Impact and Influence 🌍

The impact of Sun Hui’s work extends beyond academia, influencing diverse sectors such as defense, healthcare, and environmental monitoring. His advancements in sensor big data and AI have improved predictive analytics in critical systems, ensuring better resource allocation and risk mitigation.

As an educator, Sun Hui has shaped the careers of numerous students, many of whom have gone on to achieve significant milestones in academia and industry. His commitment to mentorship and collaboration has fostered an inclusive environment where innovation thrives.

Legacy and Future Contributions 🌟

Sun Hui’s legacy is firmly rooted in his ability to merge theoretical expertise with practical applications, addressing real-world challenges with innovative solutions. His work on the “Intelligence+” framework represents a paradigm shift, promising to redefine how scientific research is conducted in the AI era.

Looking ahead, Sun Hui aims to further his exploration of AI for Science, focusing on areas such as quantum computing, climate modeling, and personalized healthcare. He envisions a future where interdisciplinary collaboration powered by AI drives breakthroughs that benefit humanity at large.

Through his relentless pursuit of excellence and visionary leadership, Sun Hui continues to inspire the global scientific community, leaving an indelible mark on the fields of computer science, engineering, and beyond.

Notable Publication

Time-prior-based stacking ensemble deep learning model for ship infrared automatic target recognition in complex maritime scenarios

  • Authors   : Zhang, H., Liu, C., Ma, J., Sun, H.
  • Year         :2024

SAR Neural Radiance Fields with Multi-Resolution Hash Encoding

      • Authors   : Lei, Z., Sun, H., Xu, F.
      • Journal    : International Geoscience and Remote Sensing Symposium 
      • Year         :2024

Ship Infrared Automatic Target Recognition Based on Bipartite Graph Recommendation: A Model-Matching Method

    • Authors   : Zhang, H., Liu, C., Ma, J., Sun, H.
    • Year         :2024

 

Spatiotemporal adaptive attention graph convolution network for city-level air quality prediction

Data Optimization Method for Ship Infrared Image Recognition

    • Authors   : Zhang, H., Liu, C., Ma, J., Sun, H.
    • Journal    : nternational Conference on Cyber-Physical Social Intelligence
    • Year         :2023

Mr. Sadik Abdulwehab|Personalized Medicine|Top Pharmaceutical Scientist Award

Published on by Top Pharmaceutical

Mr. Sadik Abdulwehab-Personalized Medicine-Top Pharmaceutical Scientist Award

Mr. Sadik Abdulwehab at Wallaga University, Ethiopia

Author Profile

Orcid

Early Academic Pursuits 🎓

Sadik Abdulwehab Wake began his academic journey with a strong foundation in his hometown, Ethiopia. His primary education was completed at Oda Dannisa Elementary School (2001-2009), followed by secondary education at Digalu Secondary School (2010-2012). Demonstrating academic excellence, he progressed to Sagure Preparatory School in 2012-2013. He then embarked on his higher education at Wallega University, where he earned his Bachelor of Science (BSc) in Nursing in 2017 with an impressive cumulative GPA of 3.94.

His thirst for knowledge led him to pursue a Master’s degree in Adult Health Nursing (AHN) at Jimma University, which he successfully completed in 2024, achieving another remarkable GPA of 3.92. Currently, he is advancing his scholarly pursuits as a Ph.D. fellow, reflecting his dedication to continuous learning and academic excellence.

Professional Endeavors 🏥

Sadik has accumulated over six years of professional experience, including three and a half years in clinical nursing practice and three years in academia. During his clinical tenure, he honed his expertise in patient care, especially in adult health nursing, ensuring the delivery of high-quality healthcare services.

In the academic realm, Sadik has excelled as a lecturer, sharing his knowledge and inspiring the next generation of nursing professionals. His commitment to education is evident in his involvement in mentoring and supervising students on various research projects.

Sadik also contributed to national and international research efforts, collecting data for multiple NGOs and earning recognition for his contributions. His ability to blend clinical experience with academic prowess sets him apart as a multifaceted nursing professional.

Contributions and Research Focus 🔬

Sadik’s research interests span various critical areas in healthcare. His notable projects include:

  1. Blood Donation Awareness: Investigated the knowledge, attitude, and practice of medical and health science students at Wollega University regarding blood donation (2017).
  2. Patient Engagement in Decision-Making: Explored factors influencing patient involvement in healthcare decision-making at Jimma Medical Center (2023).
  3. Patient Autonomy in Asthma Management: Analyzed autonomy levels in managing bronchial asthma and associated factors at JMC (2023).
  4. Erectile Dysfunction in Type 1 Diabetes Patients: Studied its prevalence and associated factors among T1DM patients at JMC (2023).
  5. Workplace Violence in Nursing: Conducted a systematic review and meta-analysis on workplace violence against nurses in Ethiopia (2024).

These research endeavors demonstrate Sadik’s commitment to addressing significant challenges in nursing and healthcare, ultimately aiming to improve patient outcomes and the nursing profession.

Accolades and Recognition 🏅

Sadik’s dedication to his field has earned him numerous accolades, including:

  • Recognition letters and certificates for his contributions as a data collector for NGO projects.
  • Certification for completing a masterclass course with exceptional performance, further enhancing his professional credentials.

Impact and Influence 🌍

Sadik’s contributions have had a profound impact on healthcare and academia in Ethiopia. Through his research, he has provided valuable insights into critical issues such as patient autonomy, workplace violence in nursing, and healthcare decision-making. His work serves as a foundation for policy development and practical interventions to improve healthcare delivery.

In academia, his mentorship has guided many nursing students toward achieving their academic and professional goals. His influence extends beyond the classroom, shaping the future of nursing in Ethiopia.

Legacy and Future Contributions 🌟

As a Ph.D. fellow, Sadik aims to continue his journey of scholarly excellence and professional impact. His future goals include:

  • Advancing research in adult health nursing and other critical areas of healthcare.
  • Developing innovative solutions to address workplace challenges faced by nurses.
  • Contributing to global healthcare through collaborative research and knowledge exchange.

Sadik Abdulwehab Wake’s legacy lies in his unwavering commitment to nursing, education, and research. His journey inspires countless others to strive for excellence in the pursuit of improving lives through healthcare.

Closing Thoughts 💡

With a proven track record of academic achievements, professional expertise, and impactful research, Sadik embodies the qualities of a visionary nursing leader. His aspirations align with his commitment to serving society and advancing the nursing profession, making him an invaluable asset to any institution or organization.

Notable Publication

Engagement in healthcare decision-making and associated factors among patients with chronic non-communicable diseases in Southwest Ethiopia, 2023

  • Authors   : Sadik Abdulwehab; Yeshitila Belay; Frezer Kedir; Ebrahim Yimam; Admasu Belay
  • Journal    : Epidemiology and Global Health
  • Year         :2024

Patient autonomy in self-managing their bronchial asthma exacerbation and its associated factors, 2024

      • Authors   : adik Abdulwehab; Frezer Kedir
      • Journal    : Allergy
      • Year         :2024

Erectile Dysfunction and Associated Factors among Adult Diabetic Patients in Jimma Medical Center, Southwest, Ethiopia, 2023

  • Authors   : adik Abdulwehab

 

Prof. Peng SHI|Immunotherapy|Best Researcher Award

Published on by Top Pharmaceutical

Prof. Peng SHI-Immunotherapy-Best Researcher Award

Prof. Peng SHI atCity University of Hong ,Hong Kong

Author Profile

Orcid

Early Academic Pursuits 🎓

Peng Shi’s academic journey began with a solid foundation in electrical engineering, earning a Bachelor of Engineering degree from Wuhan University, China, in 2002. His keen interest in blending engineering with biological systems led him to pursue advanced studies in biomedical engineering at Columbia University, USA, where he earned both an M.Phil. in 2006 and a Ph.D. in 2009. At Columbia, Dr. Shi honed his expertise in interdisciplinary research, laying the groundwork for his future contributions to translational neuro-engineering and bioelectronics.

Professional Endeavors 👨‍🏫

Dr. Shi’s career reflects a trajectory of academic excellence and innovation. After completing his Ph.D., he served as a Postdoctoral Fellow at the Department of Electrical Engineering, Massachusetts Institute of Technology (MIT), USA (2010–2011), where he worked alongside leading researchers to advance the frontiers of bioelectronics and synthetic biology.

In 2011, Dr. Shi joined the Department of Biomedical Engineering at the City University of Hong Kong as an Assistant Professor. His dedication and groundbreaking work earned him an early promotion to Associate Professor (with tenure) in 2016 and subsequently to Full Professor in 2020. Notably, these advancements highlight his exceptional contributions to his field within a remarkably short timeframe.

Contributions and Research Focus 🔬

Dr. Shi is a pioneer at the intersection of neuroscience and engineering, leveraging cutting-edge methodologies like nano-/micro-fabrication, bioelectronics, synthetic biology, high-resolution microscopy, and artificial intelligence. His research addresses critical challenges in translational neuro-engineering, emphasizing the development of high-throughput technologies and bioelectronic platforms to create innovative therapeutic systems.

His prolific output includes more than 90 publications in prestigious journals such as Nature Reviews Materials, Nature Biomedical Engineering, PNAS, Science Advances, and Advanced Materials. These works underscore his influence in fields spanning materials science, bioengineering, and neurotechnology. Beyond academic publishing, Dr. Shi has filed 18 patents, with several granted in the US and China. Some of these patents have served as the technological foundation for two biotech spin-offs, ANRim Biotechnology Limited and Electro-Ohmics, exemplifying the translational impact of his research.

Accolades and Recognition 🏅

Dr. Shi’s excellence in research and innovation has been recognized with numerous prestigious awards and appointments:

  • 2015: Awarded the 1000 Young Talent Program by the National Natural Science Foundation of China (NSFC), a testament to his exceptional potential in scientific leadership.
  • 2018: Received the Special Recognition for Young Scholars from the World Cultural Council for his contributions to advancing global scientific understanding.
  • 2022: Appointed as Associate Editor of Brain Research (Elsevier), reflecting his influence in shaping the field of neuroscience.
  • 2023: Selected for the Biology and Medicine Panel of the Hong Kong RGC Joint Research Schemes, recognizing his leadership in biomedical research.

Dr. Shi has also delivered over 100 invited talks at global conferences, workshops, and academic institutions, further solidifying his reputation as a thought leader.

Impact and Influence 🌍

Dr. Shi’s innovations have a far-reaching impact, bridging the gap between basic research and clinical applications. His high-throughput bioelectronic platforms are revolutionizing therapeutic strategies, particularly in the realm of neuro-engineering. The biotech companies he co-founded, such as ANRim Biotechnology Limited, have secured significant funding, including RMB15M in angel investments, and are valued at HKD70M, demonstrating his success in translating academic research into viable commercial solutions.

As a grant referee for organizations like the NSFC, European Research Council, and Hong Kong UGC, Dr. Shi contributes to shaping the global research landscape. His expertise is further acknowledged through his role as a manuscript reviewer for leading publishers such as Nature, Wiley, and Elsevier.

Legacy and Future Contributions 🌟

Dr. Peng Shi’s work is paving the way for the next generation of therapeutic technologies and bioelectronic systems. By fostering interdisciplinary collaborations and mentoring emerging scholars, he is shaping the future of biomedical engineering. His patents and spin-offs ensure that his innovations continue to benefit society, bridging the divide between academia and industry.

Looking forward, Dr. Shi is poised to expand his influence through groundbreaking discoveries in synthetic biology, neuro-engineering, and artificial intelligence, driving advancements in healthcare and enhancing human well-being. His legacy will undoubtedly inspire future researchers and innovators, cementing his status as a transformative figure in biomedical engineering.

Notable Publication

Multifunctional Hydrogel Electronics for Closed-loop Antiepileptic Treatment

  • Authors   :Yuan WANG; Guangyu ZHU; Shu Chen; Chenjie Xu; Kai Xie; Jin Qu; Peng SHI; xingdao he
  • Journal    : Science Advances
  • Year         :2024

Few-shot meta-learning applied to whole brain activity maps improves systems neuropharmacology and drug discovery

      • Authors   : Xuan Luo; Yanyun Ding; Yi Cao; Zhen LIU; Wenchong Zhang; Shangzhi Zeng; Shuk Han Cheng; Honglin Li; Stephen J
      • Journal    : iScience
      • Year         :2024

Integrated Piezoelectric Vascular Graft for Continuous Real-Time Hemodynamics Monitoring

  • Authors   : Zhiqiang Ma; Weibin Jia; Jing ZHANG; xingdao he; Shiyuan Liu; Mohamed Elhousseini Hilal; Xiang ZHOU
  • Journal    : Functional Materials
  • Year         :2024

Nanopores-templated CNT/PDMS Microcolumn Substrate for the Fabrication of Wearable Triboelectric Nanogenerator Sensors to Monitor Human Pulse and Blood Pressure

  • Authors   :Tao Zhang; Chuanjie Yao; Xingyuan Xu; Zhibo Liu; Zhengjie Liu; Tiancheng Sun; Shuang Huang.
  • Journal     : Materials Technologies
  • Year         :2024                                                                                                                                                                                                                                                                                                                                                                                                          

Deciphering the Temporal–Spatial Interactive Heterogeneity of Long Non-Coding RNAs and RNA-Binding Proteins in Living Cells at Single-Cell Resolution

  • Authors   : Deyuan Yang; Cheng Li; Yutong Kong; Yian Pei; Bing Miao; Gaole Dai; Pi Ding; Peng Shi; Zixun
  • Journal     : American Chemical Society
  • Year         :2024          

Prof. Dr. Federico Hawkins|Personalized Medicine|Excellence in Research

Published on by Top Pharmaceutical

Prof. Dr. Federico Hawkins-Personalized Medicine-Excellence in Research

Prof. Dr. Federico Hawkins at Universidad Complutense Madrid ,Spain

Author Profile

Scopus

🎓 Early Academic Pursuits

Federico Gilberto Hawkins Carranza embarked on a remarkable academic journey in the field of medicine, earning his General Physician degree from the University of Salamanca in 1969. This was followed by his pursuit of higher education, where he completed a Ph.D. thesis titled “Mechanism of Action of Gastrointestinal Hormones upon Pancreas” under the mentorship of Prof. Dr. Manuel Serrano Ríos at the University Autónoma of Madrid in 1978.

During this period, Dr. Hawkins also obtained a Diploma in Psychology from the Pontifical University of Salamanca (1969) and completed his Internship and Residency at Fundación Jiménez Díaz (1969–1972), specializing in Internal Medicine and Endocrinology in 1973. His thirst for knowledge led him to prestigious institutions worldwide through scholarships, including the Endocrine Unit at Hammersmith Hospital in London (1977) and the Transplant Unit at Minnesota University (1980).

💼 Professional Endeavors

Dr. Hawkins began his illustrious career as a physician in the Service of Endocrinology at University Hospital 12 de Octubre, Madrid, in 1973. By 1979, he rose to the position of Chief of Service of Endocrinology, a role he held until 2016. His contributions to clinical endocrinology were instrumental in shaping the department into a hub of innovation and excellence.

Parallel to his clinical work, Dr. Hawkins was an active academician. In 1978, he was appointed Professor of Medicine at Complutense University of Madrid and eventually became the Chairman of Medicine in 2000. Post-retirement, he continued to serve as a Consultant at the Research Institute i+12 at University Hospital 12 de Octubre.

🔬 Contributions and Research Focus

Dr. Hawkins made pioneering contributions to endocrinology, focusing on diabetes, thyroid diseases, and postmenopausal osteoporosis.

Diabetes Mellitus:

  • Developed and implemented Radioimmunoassays (RIA) for insulin and glucagon in Spain.
  • Conducted studies on insulin secretion in chromosomal disorders, including Klinefelter’s and Down syndromes.
  • Demonstrated the hypoglycemic effects of fig tree decoctions in animals and humans.

Thyroid Diseases:

  • Advanced the understanding of thyrocalcitonin fractions in neoplasia and thyroid cancer.
  • Investigated the relationship between TSH suppression and bone mass.

Postmenopausal Osteoporosis:

  • Played a key role in clinical trials for drugs such as Alendronate, Risedronate, Teriparatide, and Strontium Ranelate.
  • Actively participated in drafting the Spanish Guide for Osteoporosis, contributing to patient care protocols.

🏆 Accolades and Recognition

Dr. Hawkins’ expertise and leadership were widely acknowledged:

  • He was appointed as an Academician Correspondent at the Royal Academy of Medicine in 2017.
  • Received honorary titles such as Extraordinary Professor at the Faculty of Medicine in Panama (2016).
  • Served as the Director of the Revista Española de Enfermedades Metabólicas and a reviewer for prestigious journals, including Current Medical Research & Opinion.

🌍 Impact and Influence

Dr. Hawkins significantly influenced the global medical community through his research and teaching. His studies on bone mass in diabetics and early markers of bone loss have been foundational in advancing treatment strategies. As an academician, he nurtured generations of physicians and researchers, promoting excellence in clinical endocrinology.

🏛️ Legacy and Future Contributions

Even in retirement, Dr. Hawkins remains a towering figure in endocrinology. His dedication to patient care, innovative research, and teaching has left a lasting legacy. His work on endocrine disorders, especially diabetes and osteoporosis, continues to shape clinical practices worldwide. Dr. Hawkins also actively contributes to medical guidelines and collaborates with researchers globally, ensuring his insights continue to benefit humanity.

Notable Publication

Socioeconomic status, osteoporosis and fragility fractures | Estatus socioeconómico, osteoporosis y fracturas por fragilidad

  • Authors   : Martínez-Díaz-Guerra, G., Hawkins Carranza, F., Librizzi, S.
  • Year         :2024

Health-Related Quality of Life Long-Term Study in Lung Transplant Patients: A Single-Center Experience

      • Authors   : Monteagudo, L.J., Diaz-Guerra, G.M., Badillo, A.Á., … Arriscado, C.M., Hawkins Carranza, F.
      • Year         :2024

Comparison of Bone Mineral Density and Trabecular Bone Score in Patients with and without Vertebral Fractures and Differentiated Thyroid Cancer with Long-Term Serum Thyrotrophin-Suppressed Therapy

  • Authors   : Hawkins Carranza, F., Arroba, C.M.-A., López Alvarez, M.B., Librizzi, S., Martínez Díaz Guerra, G.

Incidence of type 2 diabetes in the elderly in Central Spain: Association with socioeconomic status, educational level, and other risk factors

  • Authors   :Hawkins Carranza, F., Corbatón-Anchuelo, A., Bermejo Pareja, F., … Benito-León, J., Serrano-Ríos, M.
  • Journal     : Primary Care Diabetes
  • Year         :2022                                                                                                                                                                                                                                                                                                                                                                                                           

Association of Low Serum 25OHD Levels with Abnormal Bone Microarchitecture in Well-Differentiated Thyroid Cancer

  • Authors   :Hawkins Carranza, F., Guadalix Iglesias, S., De Mingo Dominguez, M.L., … Alvares, B.L., Martínez Diaz-Guerra, G.